Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
12 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to 20/20 Biolabs, Inc.’s names, not what it holds today.
Patents granted
12
12 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against 1 in 2024 and 2 in 2023
Applications published
21
1 of them in 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
'03'04'05'10'13'14'15'17'18'19'20'21'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Computer technology2
Analysis of biological materials1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
20/20 GeneSystems Inc. a former name
US, as the owner printed on each patent
20 published20/20 GeneSystems Inc. a former name
named as the applicant on its applications, in US
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jul 30, 2024 | 12,051,509 | Methods and machine learning systems for predicting the likelihood or risk of having cancer | Computer technology | 20/20 GeneSystems Inc. |
| Aug 22, 2023 | 11,733,249 | Methods and algorithms for aiding in the detection of cancer | Analysis of biological materials | 20/20 GeneSystems Inc. |
| Apr 4, 2023 | 11,621,080 | Methods and machine learning systems for predicting the likelihood or risk of having cancer | Computer technology | 20/20 GeneSystems Inc. |
| Sep 15, 2020 | 10,774,358 | Method for increasing available protein from endospores for detection purposes | Analysis of biological materials | 20/20 GeneSystems Inc. |
| Dec 18, 2018 | 10,156,575 | Methods and algorithms for aiding in the detection of cancer | Analysis of biological materials | 20/20 GeneSystems Inc. |
| Sep 5, 2017 | 9,753,043 | Methods and algorithms for aiding in the detection of cancer | Analysis of biological materials | 20/20 GeneSystems Inc. |
| Jul 15, 2014 | 8,779,312 | Method and device for analyzing biomolecules with track-etched polymeric layers | Analysis of biological materials | 20/20 GeneSystems Inc. |
| Nov 23, 2010 | 7,838,222 | Methods, devices and kits for multiplex blotting of biological samples from multi-well plates | Analysis of biological materials | 20/20 GeneSystems Inc. |
| Nov 29, 2005 | 6,969,615 | Methods, devices, arrays and kits for detecting and analyzing biomolecules | Measurement | 20/20 GeneSystems Inc. |
| Oct 25, 2005 | 6,958,242 | Rapid assay, method and system for detecting biowarfare agents | Analysis of biological materials | 20/20 GeneSystems Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Mar 13, 2025 | 2025/0087364 | METHODS AND MACHINE LEARNING SYSTEMS FOR PREDICTING THE LIKELIHOOD OR RISK OF HAVING CANCER | Computer technology | 20/20 GeneSystems Inc. |
| Apr 4, 2024 | 2024/0112811 | METHODS AND MACHINE LEARNING SYSTEMS FOR PREDICTING THE LIKELIHOOD OR RISK OF HAVING CANCER | Computer technology | 20/20 GeneSystems Inc. · patent 12,051,509 granted from it |
| Dec 7, 2023 | 2023/0393150 | METHODS AND ALGORITHMS FOR AIDING IN THE DETECTION OF CANCER | Analysis of biological materials | 20/20 GeneSystems Inc. |
| Aug 24, 2023 | 2023/0263477 | UNIVERSAL PAN CANCER CLASSIFIER MODELS, MACHINE LEARNING SYSTEMS AND METHODS OF USE | Computer technology | 20/20 GeneSystems Inc. |
| Jul 13, 2023 | 2023/0223145 | METHODS AND SOFTWARE SYSTEMS TO OPTIMIZE AND PERSONALIZE THE FREQUENCY OF CANCER SCREENING BLOOD TESTS | Medical technology | 20/20 GeneSystems Inc. |
| Nov 11, 2021 | 2021/0348237 | METHODS AND COMPOSITIONS FOR AIDING IN THE DETECTION OF LUNG CANCER | Analysis of biological materials | 20/20 GeneSystems Inc. |
| Aug 19, 2021 | 2021/0256323 | METHODS AND COMPOSITIONS FOR AIDING IN DISTINGUISHING BETWEEN BENIGN AND MALIGANNT RADIOGRAPHICALLY APPARENT PULMONARY NODULES | Medical technology | 20/20 GeneSystems Inc. |
| Jan 2, 2020 | 2020/0005901 | CANCER CLASSIFIER MODELS, MACHINE LEARNING SYSTEMS AND METHODS OF USE | Computer technology | 20/20 GeneSystems Inc. |
| Jun 13, 2019 | 2019/0178895 | METHODS AND ALGORITHMS FOR AIDING IN THE DETECTION OF CANCER | Analysis of biological materials | 20/20 GeneSystems Inc. · patent 11,733,249 granted from it |
| May 2, 2019 | 2019/0131016 | METHODS AND COMPOSITIONS FOR AIDING IN DISTINGUISHING BETWEEN BENIGN AND MALIGANNT RADIOGRAPHICALLY APPARENT PULMONARY NODULES | Medical technology | 20/20 GeneSystems Inc. |
What it applied for, 2024 to 2025: Computer technology 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.